Who has invested in Pathos?

Revolution, Lightbank, Builders VC, NEA are named among the investors backing Pathos.

Pathos Funding: $345M Raised, Series D (2025)

Pathos funding overview

Pathos is a Biotech company based in Chicago, IL. Pathos has raised $345M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in April 2025. The round record for Pathos runs through 2025; nothing later has been disclosed. Investors on record include Revolution, Lightbank, Builders VC, NEA. 4 distinct backers are named across the disclosed rounds.

Pathos at a glance

Total raised: $345M
Latest round: Series D
Latest round date: April 2025
Industry: Biotech
Headquarters: Chicago, IL
Notable investors: Revolution, Lightbank, Builders VC, NEA

Frequently asked about Pathos funding

How much has Pathos raised?: Pathos has raised $345M in total disclosed funding across the rounds on record.
Who has invested in Pathos?: Revolution, Lightbank, Builders VC, NEA are named among the investors backing Pathos.
What was the latest Pathos funding round?: The most recent disclosed round is a Series D, announced in April 2025.
Where is Pathos based?: Pathos is based in Chicago, IL.
What sector does Pathos operate in?: Pathos is tracked under Biotech from Chicago, IL, with $345M in disclosed funding.
When did Pathos last raise?: The last disclosed Pathos round closed in April 2025 at Series D.

Pathos totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Chicago below to benchmark round size and investor mix.

Pathos Funding: $345M Raised, Series D (2025)

Pathos funding overview

Pathos at a glance

Frequently asked about Pathos funding

Pathos founders (1)

Companies related to Pathos (40)

Browse related funding lists (6)